Amlogenyx

United States
Elk Grove Village, Illinois, United States
+1 415-231-3300 ★

Company profile

Amlogenyx company profile

Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease. It is a spin-off from Ultragenyx Pharmaceutical.

Business identity

Contact email
[email protected]
Phone number
+1 415-231-3300
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Founded
2023-01-01

Headquarters

Headquarters
Elk Grove Village, Illinois, United States
Postal code
02143
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$14M
Last funding
Seed / $14M / 2024-08-02
Last equity funding
Seed / $14M
Investors
2
Lead investors
1
Articles
2

Founders and investors

Lead investors

GordonMD Global Investments

Investors

GordonMD Global InvestmentsUltragenyx Pharmaceutical

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.